Medical Bionics Market Scope
Medical bionics devices electrically stimulate excitable tissue, including nerve and muscle, to provide therapeutic intervention for a large variety of maladies. Examples include the cardiac pacemaker to assist heart pacing, the cochlear implant for hearing disorders, deep brain stimulation to relieve symptoms in a variety of neurological diseases including Parkinson’s disease, essential tremor, and obsessive-compulsive disorder, and stimulation devices to relieve drug-resistant neuropathic pain.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | Advanced Bionics (United States), Mobiusbionics (United States), Edwards Lifesciences (United States), Ekso Bionics (United States), Cochlear (Australia), LifeNet Health (United States), Retina Implant (Germany), Orthofix International (United States), William Demant (Denmark), SECOND SIGHT (United States) and SynCardia Systems (United States) |
CAGR | 8.7% |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Medical Bionics market throughout the predicted period.
Advanced Bionics (United States), Mobiusbionics (United States), Edwards Lifesciences (United States), Ekso Bionics (United States), Cochlear (Australia), LifeNet Health (United States), Retina Implant (Germany), Orthofix International (United States), William Demant (Denmark), SECOND SIGHT (United States) and SynCardia Systems (United States) are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Medical Bionics market by Type , by Application (Implantable and Externally Worn) and Region with country level break-up.
On the basis of geography, the market of Medical Bionics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In February 2022, Ceryx Medical launched Cysoni bionic device for respiratory sinus arrhythmia. It is noted that the Cysoni device replicates RSA, triggering heartbeats based on respiratory function.
In July 2022, Prosthetics startup Unlimited Tomorrow launched TrueLimb, its next-generation bionic arm. The hands have independent finger joints and six adaptive grips, which conform to objects the wearer comes in contact with, and subtle vibrations.
Influencing Trend:
Improvement And Modification In Bionics With Numerous Length And Size Options
Market Growth Drivers:
Growing Prevalence Of Eye Diseases Advanced Bionics and Rise In Number Of Cases Of Amputees Due To Accidents And Injuries
Challenges:
Limited Surgical Expertise
Restraints:
High Rate Of Organ Treatment
Opportunities:
Increase In Geriatric Population And Associated Organ Failure
Key Target Audience
Medical Bionics Providers, New Entrants and Investors, Hospitals and Clinics, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others